PCM
THMO

Prelude Capital Management’s ThermoGenesis Holdings, Inc. Common Stock THMO Stock Holding History

Prelude Capital Management’s Portfolio THMO Stock Details THMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-573
Closed -$75K – 2131
2020
Q3 		$75K Buy
+573
New +$112K ﹤0.01% 1007

Other funds holding THMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Prelude Capital Management's THMO Position: Q4 2020 in Review

Prelude Capital Management sold out of ThermoGenesis Holdings, Inc. Common Stock (THMO) in Q4 2020, closing a stake of 573 shares — an estimated $75K sold.

Prelude Capital Management first reported a position in THMO in Q3 2020 and held it in 1 quarter. The position peaked at $75K in Q3 2020. 13 funds tracked by Wall St. Rank hold THMO as of Q4 2020.

  • Prelude Capital Management reported no remaining ThermoGenesis Holdings, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 573 ThermoGenesis Holdings, Inc. Common Stock shares in Q4 2020, an estimated $75K.
  • Prelude Capital Management first reported a position in ThermoGenesis Holdings, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Prelude Capital Management's ThermoGenesis Holdings, Inc. Common Stock position peaked at $75K in Q3 2020.
  • 13 funds tracked by Wall St. Rank held ThermoGenesis Holdings, Inc. Common Stock as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.